Monday, November 12, 2012

Corporate Integrity? Professionalism? Give Us a Break

›
"The rich are different from you and me." "Yes, they have less integrity." I'll return at the end to this exchang...
1 comment:
Wednesday, November 7, 2012

A Non-Psychiatrist Dares to Comment on Psychiatry

›
I have occasionally posted about the controversy aroused by the American Psychiatric Association's (APA)forthcoming DSM-V classification...
2 comments:
Monday, November 5, 2012

Let's Do It Again: Latest Federal Settlement (Boehringer Ingelheim)

›
We are back to our standard form, to report the latest incident of a drug firm settling with the Feds over alleged lawbreaking: Drug compa...
1 comment:
Saturday, November 3, 2012

Roses (and Thorns) by Any Other Name: ACRE's New "Guidelines"

›
I have blogged at length about the Association of Clinical Researchers and Educators (ACRE), the primary outlet for pharmapologist sentiment...
Monday, October 29, 2012

When the Marketing Tail Wags the Research Dog: More on Medtronic and InFuse

›
I have posted a number of times on the case of Medtronic, its payments (bribes) to spine surgeons, and its product BMP-2 or InFuse: http://...
Thursday, October 25, 2012

Against Capitalism?

›
One of my most faithful pen-pals (if such a term can be applied to people who send me e-mails) shipped over this link: http://dissidentvoic...
5 comments:
Wednesday, October 24, 2012

Yet More from the Belly of the Beast: Pfizer's Campaign to Market Neurontin Off-Label

›
Thanks as so often to Dr. Roy Poses over at Health Care Renewal-- http://hcrenewal.blogspot.com/2012/10/when-clinical-trials-are-meant-for....
2 comments: